Page last updated: 2024-12-10

aluminum magnesium silicate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth

Description

aluminum magnesium silicate: RN given refers to cpd with unspecified composition [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID168265959
MeSH IDM0102749

Synonyms (3)

Synonym
aluminum magnesium silicate
CS-0694384
HY-154703

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Several edible and safe lipids, surfactants and cosolvents were screened for solubilization of resevratrol."( Lipid based nanoemulsifying resveratrol for improved physicochemical characteristics, in vitro cytotoxicity and in vivo antiangiogenic efficacy.
Joshi, A; More, U; Pund, S; Thakur, R, 2014
)
0.4

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic parameter values (mean +/- RSD) of piroxicam after administration of droxicam alone were: AUC0-->infinity = 125."( A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
Maya, MT; Morais, JA; Pais, JP; Ruas Da Silva, J,
)
0.13

Bioavailability

ExcerptReferenceRelevance
" These results indicate that concurrent administration of the antacid does not significantly change the bioavailability and pharmacokinetics of droxicam."( A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
Maya, MT; Morais, JA; Pais, JP; Ruas Da Silva, J,
)
0.13
"To determine whether the observed decrease in tetracycline bioavailability is due to the active drug bismuth subsalicylate via complexation, or to magnesium aluminum silicate (Veegum), an inactive excipient present only in the liquid formulation of bismuth subsalicylate, which might adsorb the tetracycline, rendering it unavailable for systemic absorption."( Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
Clendening, CE; Dansereau, RJ; Deepe, GS; Dunn, AB; Healy, DP; Mounts, AW, 1997
)
0.3
" The bioavailability of CyA from SMEDDS loaded into disintegrating LLT was found in the second study to be at the same level as from capsule formulation."( Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation.
Holm, P; Sander, C, 2009
)
0.35
" In general, the water solubility of the monomeric Al materials depends on pH and their water solubility and gastrointestinal bioavailability are much greater than that of the hydrated Al silicates."( Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
Ball, GL; McLellan, CJ; Willhite, CC, 2012
)
0.38
" The bioavailability of danazol after oral administration to rats was also assessed."( Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier.
Anby, MU; Augustijns, P; Nguyen, TH; Porter, CJ; Van Speybroeck, M; Williams, HD, 2012
)
0.38
"The aim of this study was to enhance the bioavailability of fenofibrate, a poorly water-soluble drug, using a melt-adsorption method with supercritical CO(2)."( Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide.
Cha, KH; Cho, KJ; Cho, W; Hwang, SJ; Kim, JS; Kim, MS; Park, HJ; Park, J; Park, JS, 2012
)
0.38
" In vitro dissolution and in vivo bioavailability were also investigated."( Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide.
Cha, KH; Cho, KJ; Cho, W; Hwang, SJ; Kim, JS; Kim, MS; Park, HJ; Park, J; Park, JS, 2012
)
0.38
"The results of this study highlight the usefulness of the melt-adsorption method using supercritical CO(2) for improving the bioavailability of fenofibrate."( Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide.
Cha, KH; Cho, KJ; Cho, W; Hwang, SJ; Kim, JS; Kim, MS; Park, HJ; Park, J; Park, JS, 2012
)
0.38
"Solid lipid formulation systems are used to overcome oral bioavailability problems of poorly water-soluble drugs."( Toward a detailed characterization of oil adsorbates as "solid liquids".
Kutza, C; Kutza, J; Mäder, K; Metz, H; Syrowatka, F, 2013
)
0.39
" The present study is aimed to enhance the dissolution and oral bioavailability of water-insoluble RTV using the Solid Self-Microemulsifying Drug Delivery System (S-SMEDDS)."( Solid self-microemulsifying drug delivery system of ritonavir.
Deshmukh, A; Kulkarni, S, 2014
)
0.4
"To enhance the dissolution and oral bioavailability of water-insoluble RTV using the S-SMEDDS."( Solid self-microemulsifying drug delivery system of ritonavir.
Deshmukh, A; Kulkarni, S, 2014
)
0.4
" Relative bioavailability of RTV was determined in male Wistar rats and pharmacokinetic parameters were calculated by the comparison of optimized S-SMEDDS versus aqueous suspension of RTV."( Solid self-microemulsifying drug delivery system of ritonavir.
Deshmukh, A; Kulkarni, S, 2014
)
0.4
"S-SMEDDS tablet of RTV was formulated successfully by adsorbing optimized L-SMEDDS of RTV on Neusilin-US2(®) as a potential carrier with enhanced solubility and relative oral bioavailability compared to pure RTV by twofolds."( Solid self-microemulsifying drug delivery system of ritonavir.
Deshmukh, A; Kulkarni, S, 2014
)
0.4
" To improve the solubility and in turn bioavailability of cilostazol, a lipid based nanoemulsifying cilostazol was developed."( Multivariate analysis of physicochemical characteristics of lipid based nanoemulsifying cilostazol--quality by design.
Jagadale, S; Pund, S; Shete, Y, 2014
)
0.4
" However, poor aqueous solubility and cellular bioavailability has limited its therapeutic application."( Lipid based nanoemulsifying resveratrol for improved physicochemical characteristics, in vitro cytotoxicity and in vivo antiangiogenic efficacy.
Joshi, A; More, U; Pund, S; Thakur, R, 2014
)
0.4
"Liquisolid systems are an innovative dosage form used for enhancing dissolution rate and improving in vivo bioavailability of poorly soluble drugs."( Modern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods.
Gajdziok, J; Vetchý, D; Vraníková, B, 2015
)
0.42
"The preparation of liquisolid systems (LSS) represents a promising method for enhancing a dissolution rate and bioavailability of poorly soluble drugs."( The effect of superdisintegrants on the properties and dissolution profiles of liquisolid tablets containing rosuvastatin.
Doležel, P; Gajdziok, J; Vraníková, B, 2017
)
0.46
"The purpose of this study was to assess the impact of inorganic mesoporous carriers on the physicochemical properties and oral bioavailability of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG)-loaded solid self-emulsifying drug delivery system (solid SEDDS)."( Effect of inorganic mesoporous carriers on 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol-loaded solid self-emulsifying drug delivery system: Physicochemical characterization and bioavailability in rats.
Choi, HG; Jin, SG; Kim, DS; Kim, JO; Li, DX; Oh, KT; Yang, ES; Yong, CS; Youn, YS, 2017
)
0.46
"The aim of the present investigation entails the development of solid SMEDDS for improving the oral bioavailability of canagliflozin using porous carriers."( Role of Porous Carriers in the Biopharmaceutical Performance of Solid SMEDDS of Canagliflozin.
Bedi, N; Singh, D; Tiwary, AK, 2018
)
0.48
" Enhanced in vitro dissolution rate of optimized solid SMEDDS manifested in bioavailability enhancement of 167."( Role of Porous Carriers in the Biopharmaceutical Performance of Solid SMEDDS of Canagliflozin.
Bedi, N; Singh, D; Tiwary, AK, 2018
)
0.48
"The present investigation reveals the immense potential of solid SMEDDS in augmenting the oral bioavailability profile of poorly water-soluble drug canagliflozin."( Role of Porous Carriers in the Biopharmaceutical Performance of Solid SMEDDS of Canagliflozin.
Bedi, N; Singh, D; Tiwary, AK, 2018
)
0.48
"The aim of this study was to solidify a ticagrelor loaded self-microemulsifying drug delivery system (TCG-SM) with enhanced dissolution and bioavailability of ticagrelor (TCG) for developing TCG-SM granules and tablets."( Statistical approach for solidifying ticagrelor loaded self-microemulsifying drug delivery system with enhanced dissolution and oral bioavailability.
Bang, KH; Byeon, JJ; Cho, CW; Han, MG; Huh, HW; Kim, MK; Lee, HK; Na, YG; Wang, M, 2019
)
0.51
" The current study entails development and evaluation of spray dried lipid based formulation (solid SMEDDS) for enhancing oral bioavailability and anti-diabetic activity of CFZ."( Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm.
Arora, S; Bedi, N; Kesavan, AK; Singh, AP; Singh, D; Tiwary, AK, 2020
)
0.56
" Graphical abstract Graphical Abstract: Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm."( Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm.
Arora, S; Bedi, N; Kesavan, AK; Singh, AP; Singh, D; Tiwary, AK, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" The sorption of bromhexine base and bromhexine HCl to packaging material were compared using tablet dosage forms."( Interaction between polyethylene films and bromhexine HCl in solid dosage form. IV. Prevention of the sorption by addition of magnesium aluminum silicate.
Kukita, T; Nemoto, M; Okamoto, A; Yamaguchi, A, 1992
)
0.28
" The scope of this novel dosing methodology is demonstrated through the evaluation of 14 diverse organic reactions, including Mitsunobu, Suzuki, and bromination reactions."( Nanoporous magnesium aluminometasilicate tablets for precise, controlled, and continuous dosing of chemical reagents and catalysts: applications in parallel solution-phase synthesis.
Christensen, CH; Holm, P; Nielsen, SD; Ruhland, T,
)
0.13
" This finding suggests that the PPN-MAS complexes obtained in this study are strong candidates for use as drug carriers in oral modified-release dosage forms."( Propranolol-magnesium aluminum silicate complex dispersions and particles: characterization and factors influencing drug release.
Pongjanyakul, T; Rojtanatanya, S, 2010
)
0.36
" In conclusion, the LLT technology is therefore seen as a promising alternative way of achieving a solid dosage form from liquid drug delivery systems."( Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation.
Holm, P; Sander, C, 2009
)
0.35
"An adequate drug dissolution behavior is essential for the therapeutic effectiveness of all solid dosage forms."( New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs.
Cirri, M; Mennini, N; Mura, P; Valleri, M,
)
0.13
"In solid oral dosage forms silicates are commonly used as glidants in low concentration."( Tableting properties of silica aerogel and other silicates.
Alnaief, M; Hentzschel, CM; Leopold, CS; Sakmann, A; Smirnova, I, 2012
)
0.38
" The obtained new knowledge can be helpful for the development of novel coating materials (based on QPM-MAS blends) for controlled-release dosage forms."( Quaternary polymethacrylate-magnesium aluminum silicate films: Water uptake kinetics and film permeability.
Pongjanyakul, T; Rongthong, T; Siepmann, F; Siepmann, J; Sungthongjeen, S, 2015
)
0.42
"Liquisolid systems are an innovative dosage form used for enhancing dissolution rate and improving in vivo bioavailability of poorly soluble drugs."( Modern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods.
Gajdziok, J; Vetchý, D; Vraníková, B, 2015
)
0.42
"Adsorption of lipid-based formulations, which are usually liquid, onto silicas has been extensively investigated in the past decade to convert them into solid dosage forms."( Development of solid SEDDS, VI: Effect of precoating of Neusilin
Freire, BOS; Gumaste, SG; Serajuddin, ATM, 2017
)
0.46
"The purpose of this study was to develop self-microemulsifying (SME-) tablets to improve resveratrol solubility whilst delivering resveratrol in a preferred tablet dosage form."( Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.
Bolko Seljak, K; Gašperlin, M; Ilić, IG; Zvonar Pobirk, A, 2018
)
0.48
"6-fold greater inhibitory response over 60 min, compared to dosing orlistat alone."( Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity.
Dening, TJ; Gustafsson, H; Joyce, P; Kovalainen, M; Meola, TR; Prestidge, CA, 2019
)
0.51
"The work was aimed at evaluating the efficiency of multifunctional magnesium aluminosilicate materials (MAS) as a novel glidant in solid dosage forms."( Evaluation of multifunctional magnesium aluminosilicate materials as novel family of glidants in solid dosage products.
Komínová, P; Kulaviak, L; Tran, DT; Zámostný, P, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Baby & Kids Products1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Babyganics Mosquito Repellent Lotion -- 4 fl ozBabyganicsBaby & Kids Productsaluminum magnesium silicate, glyceryl stearate, glycerin, isopropyl myristate, sodium benzoate, stearic acid2024-11-29 10:47:42

Research

Studies (110)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (14.55)18.7374
1990's4 (3.64)18.2507
2000's19 (17.27)29.6817
2010's59 (53.64)24.3611
2020's12 (10.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (5.22%)5.53%
Reviews2 (1.74%)6.00%
Case Studies1 (0.87%)4.05%
Observational0 (0.00%)0.25%
Other106 (92.17%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]